Cargando…
Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis?
Leishmaniasis is a neglected disease, which needs improvements in drug development, mainly due to the toxicity, parasite resistance and low compliance of patients to treatment. Therefore, the development of new chemotherapeutic compounds is an urgent need. This opinion article will briefly highlight...
Autores principales: | ENNES-VIDAL, VITOR, MENNA-BARRETO, RUBEM FIGUEIREDO SADOCK, BRANQUINHA, MARTA HELENA, DOS SANTOS, ANDRÉ LUIS SOUZA, D'AVILA-LEVY, CLAUDIA MASINI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300003/ https://www.ncbi.nlm.nih.gov/pubmed/27869056 http://dx.doi.org/10.1017/S003118201600189X |
Ejemplares similares
-
Expression and cellular localisation of Trypanosoma cruzi calpains
por: Ennes-Vidal, Vítor, et al.
Publicado: (2020) -
MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut
por: Ennes-Vidal, Vítor, et al.
Publicado: (2011) -
The Diverse Calpain Family in Trypanosomatidae: Functional Proteins Devoid of Proteolytic Activity?
por: Ennes-Vidal, Vítor, et al.
Publicado: (2021) -
Calpains of Leishmania braziliensis: genome
analysis, differential expression, and functional analysis
por: Ennes-Vidal, Vítor, et al.
Publicado: (2019) -
Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022)